Vernolepin
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 18542-37-5
- 화학식: C15H16O5
- 분자량:276.29
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
16.9 μM
Compound: 5
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by WST-8 assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by WST-8 assay
|
[PMID: 27311895] |
| HeLa | IC50 |
2.2 μM
Compound: 5
|
Antiproliferation activity against human HeLa cells assessed as reduction in cell viability after 72 hrs by WST-8 assay
Antiproliferation activity against human HeLa cells assessed as reduction in cell viability after 72 hrs by WST-8 assay
|
[PMID: 27311895] |
| MDA-MB-231 | IC50 |
1.9 μM
Compound: 5
|
Antiproliferation activity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by WST-8 assay
Antiproliferation activity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by WST-8 assay
|
[PMID: 27311895] |
In Vitro
-
Cell Line:A549, HeLa, HuCCA-1, HepG2, H69AR, T47-D, MDA-MB-231, S102, HL-60, MOLT-3, MRC-5
-
Concentration:0.016-50 μg/mL
-
Incubation Time:48 h
-
Result:Exhibited cytotoxic activity across all tested cancer cell lines with the following IC50 values: 13.73 μM (A549), 11.27 μM (HeLa), 9.31 μM (HuCCA-1), 20.15 μM (HepG2), 8.70 μM (H69AR), 9.31 μM (T47-D), 19.35 μM (MDA-MB-231), 30.58 μM (S102), 3.84 μM (HL-60), 5.29 μM (MOLT-3).
Showed selective cytotoxicity with selectivity indices ≥3.0 across all cancer cell lines, with an IC50 of 91.49 μM against normal MRC-5 cells.
-
Cell Line:HepG2
-
Concentration:10 μM
-
Incubation Time:48 h
-
Result:Induced morphological changes and cell detachment in HepG2 cells.
Increased total apoptotic cell populations to 20.0%, compared to a basal apoptosis level of 6.7% in untreated control cells.
-
Cell Line:HepG2
-
Concentration:10 μM
-
Incubation Time:48 h
-
Result:Decreased the proportion of cells in G0/G1 (40.4%) and S (8.0%) phases.
Increased the proportion of cells in G2/M phase to 51.5%, compared to control cells with 49.8% in G0/G1, 11.6% in S, and 38.4% in G2/M.
Chemical Information
-
CAS No. 18542-37-5
-
분자량 276.29
-
화학식 C15H16O5
-
SMILES
C(=C)[C@@]12[C@@]([C@@]3([C@@]([C@@H](O)C1)(C(=C)C(=O)O3)[H])[H])(C(=C)C(=O)OC2)[H]
-
Structure Classification
-
Initial Source
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)